2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg-Reference-Cited by-同舟云学术

2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg

Published:2022-07 Issue: Volume:108 Page:108769
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Qi Wen-Hui,Zhang Yan-Yan,Xing Kun,Hao Dong-Xia,Zhang Fei,Wang Rui-Ning,Bao Ming-Yue,Tian Meng-Yuan,Yang Ya-Na,Li Xing,Zhang Yuan

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shaanxi Province

Fundamental Research Funds for the Central Universities

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference63 articles.

1. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12;Becher;Journal of Clinical Investigation,2002

2. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain;Cua;Nature,2003

3. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand;Solt;Nature,2011

4. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases;Noack;Autoimmun Rev,2014

5. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination;Rostami;J Neurol Sci,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effects and mechanisms of isoxanthohumol on DSS-induced colitis: regulating T cell development, restoring gut microbiota, and improving metabolic disorders;Inflammopharmacology;2024-04-20

2. Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence;Phytomedicine;2024-01

3. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease;World Journal of Gastroenterology;2023-07-21

4. Natural Compound 2,2′,4′-Trihydroxychalcone Suppresses T Helper 17 Cell Differentiation and Disease Progression by Inhibiting Retinoid-Related Orphan Receptor Gamma T;International Journal of Molecular Sciences;2022-11-22

5. Corrigendum to “2′, 4′-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg”. [Int. Immunopharmacol. 108 (2022) 108769];International Immunopharmacology;2022-11